At CHI/Bio-IT World's thirteenth annual Structure-Based Drug Design conference, you will hear about developments in in silico technology, as well as experimental approaches useful for accurately predicting and modeling the structures of proteins in structure-based drug design efforts. In addition, examples of successful applications of such technology approaches to genome-to-drug lead investigations will be addressed. This event is conveniently co-located with the Next-Gen Kinase Inhibitors conference (June 17-19). An all access, discounted registration pass is available to attend both conferences.

Reasons to Attend:
•HEAR about novel ligand-centric approach for force field calculation.
•BE inspired to set up ambitious projects on SBDD using automated analytics pipeline and long-timescale explicit molecular simulation.
•EXAMINE the role of water/solvent in structure-based drug design.
•RE-DISCOVER the potential of fragment-based drug design through simulation of the complete binding process.
•EXPLORE the epigenomic protein landscapes of cancer cells for drug design.
•MEET potential collaborators from both academic and industry practitioners.

Sessions:
•Structure-Based Drug Design for Kinase
•Drug Resistance
•Force Field Calculation
•GPCR
•Water & Solvation in Drug Design
•Fragment-Based Drug Design
•Protein-Protein Interaction
•Epigenetic Targeting